In The News Posted January 8, 2020 Share Posted January 8, 2020 DURHAM, N.C., Jan. 8, 2020 /PRNewswire/ -- Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biopharmaceutical industries, today announced the sale of its preclinical and early stage active pharmaceutical ingredient (API)... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.